Toward Localized In Vivo Biomarker Concentration Measurements

We know a great deal about the biochemistry of cells because they can be isolated and studied. The biochemistry of the much more complex in vivo environment is more difficult to study because the only ways to quantitate concentrations is to sacrifice the animal or biopsy the tissue. Either method disrupts the environment profoundly and neither method allows longitudinal studies on the same individual. Methods of measuring chemical concentrations in vivo are very valuable alternatives to sacrificing groups of animals. We are developing microscopic magnetic nanoparticle (mNP) probes to measure the concentration of a selected molecule in vivo. The mNPs are targeted to bind the selected molecule and the resulting reduction in rotational freedom can be quantified remotely using magnetic spectroscopy. The mNPs must be contained in micrometer sized porous shells to keep them from migrating and to protect them from clearance by the immune system. There are two key issues in the development of the probes. First, we demonstrate the ability to measure concentrations in the porous walled alginate probes both in phosphate buffered saline and in blood, which is an excellent surrogate for the complex and challenging in vivo environment. Second, sensitivity is critical because it allows microscopic probes to measure very small concentrations very far away. We report sensitivity measurements on recently introduced technology that has allowed us to improve the sensitivity by two orders of magnitude, a factor of 200 so far.

[1]  John B Weaver,et al.  Magnetic nanoparticle sensing: decoupling the magnetization from the excitation field , 2014, Journal of physics D: Applied physics.

[2]  Barjor Gimi,et al.  Molecular sensing with magnetic nanoparticles using magnetic spectroscopy of nanoparticle Brownian motion. , 2013, Biosensors & bioelectronics.

[3]  P. J. Hoopes,et al.  Noninvasive assessment of magnetic nanoparticle-cancer cell interactions. , 2012, Integrative biology : quantitative biosciences from nano to macro.

[4]  C. Bertozzi,et al.  Real-time noninvasive imaging of fatty acid uptake in vivo. , 2012, ACS chemical biology.

[5]  C. Drake,et al.  Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. , 2012, The New England journal of medicine.

[6]  Drew M. Pardoll,et al.  The blockade of immune checkpoints in cancer immunotherapy , 2012, Nature Reviews Cancer.

[7]  H. C. Yang,et al.  Universal Behavior of Biomolecule-Concentration-Dependent Reduction in AC Magnetic Susceptibility of Bioreagents , 2012, IEEE Magnetics Letters.

[8]  M. Cima,et al.  Implantable magnetic relaxation sensors measure cumulative exposure to cardiac biomarkers , 2011, Nature Biotechnology.

[9]  John B Weaver,et al.  Concurrent quantification of multiple nanoparticle bound states. , 2011, Medical physics.

[10]  John B. Weaver,et al.  Measurement of molecular binding using the Brownian motion of magnetic nanoparticle probes , 2010 .

[11]  Krishnamurthy V. Nemani,et al.  Cell encapsulation and oxygenation in nanoporous microcontainers , 2009, Biomedical microdevices.

[12]  Frank Ludwig,et al.  Binding assays with streptavidin-functionalized superparamagnetic nanoparticles and biotinylated analytes using fluxgate magnetorelaxometry , 2009 .

[13]  Barjor Gimi,et al.  A Nanoporous, Transparent Microcontainer for Encapsulated Islet Therapy , 2009, Journal of diabetes science and technology.

[14]  Thomas Ming-Hung Lee,et al.  Over-the-Counter Biosensors: Past, Present, and Future , 2008, Sensors.

[15]  T. Okazaki,et al.  PD-1 and PD-1 ligands: from discovery to clinical application. , 2007, International immunology.

[16]  Eunkeu Oh,et al.  Magnetophoretic immunoassay of allergen-specific IgE in an enhanced magnetic field gradient. , 2007, Analytical chemistry.

[17]  I. Tannock,et al.  Drug penetration in solid tumours , 2006, Nature Reviews Cancer.

[18]  Weiping Zou,et al.  Immunosuppressive networks in the tumour environment and their therapeutic relevance , 2005, Nature Reviews Cancer.

[19]  H. Blau,et al.  Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. , 2004, The Journal of clinical investigation.

[20]  R K Jain,et al.  Direct in vivo measurement of targeted binding in a human tumor xenograft. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[21]  H. Barr,et al.  Medical applications of Raman spectroscopy: from proof of principle to clinical implementation. , 2002, Biopolymers.